China Re-Infection Case Ignites Antibody Durability Debate
Threshold for Herd Immunity Also in Spotlight
Executive Summary
Amid a case of re-infection of a vaccinated healthcare worker in western China’s Xi’an city, and ongoing debate over domestic vaccines' efficacy, increasing attention is being paid in China to raising inoculation rates for COVID-19 and moving towards herd immunity.